Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL
| Autor: | Martin, Peter *, Bartlett, Nancy L., Chavez, Julio C., Reagan, John L., Smith, Sonali M., LaCasce, Ann S., Jones, Jeffrey, Drew, James, Wu, Chengqing, Mulvey, Erin, Revuelta, Maria V., Cerchietti, Leandro, Leonard, John P. |
|---|---|
| Zdroj: | In Blood 24 February 2022 139(8):1147-1159 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|